The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study aims to investigate the value of 68Ga-FAPI PET/CT in the efficacy evaluation of advanced unresectable hepatocellular carcinoma patients undergoing systemic antitumor therapy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Pathological and clinical diagnosis of advanced unresectable hepatocellular carcinoma patients.
• Signed and dated informed consent form.
• Commitment to comply with research procedures and co-operation in the implementation of the full research process.
• Aged 18-75 years old.
Locations
Other Locations
China
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
RECRUITING
Shanghai
Contact Information
Primary
Jiajia Hu
jiajiahu@shsmu.edu.cn
13524945287
Time Frame
Start Date: 2024-12-03
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 40
Treatments
Patients diagnosis of advanced unresectable hepatocellular carcinoma
Related Therapeutic Areas
Sponsors
Leads: Ruijin Hospital